Horizon Therapeutics Public Ltd Co

ING GROEP NV

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/27/2023

Shares

360,725

Value ($000)

41,732

Weight

0.4%

2023 Q1 - 2023 Q3 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/27/2023	41,732	0.4%	360,725	9/30/2023
2023 Q2	8/7/2023	28,255	0.2%	274,725	6/30/2023
2023 Q1	5/9/2023	16,623	0.2%	152,312	3/31/2023